Mobile

A 4 week double-blind, placebo-controlled, randomized, parallel group phase IIa study to assess the efficacy and safety of AZD1981 in patients with moderate to severe Chronic Obstructive Pulmonary Dis...

Mise à jour : Il y a 4 ans
Référence : EUCTR2008-000340-13

A 4 week double-blind, placebo-controlled, randomized, parallel group phase IIa study to assess the efficacy and safety of AZD1981 in patients with moderate to severe Chronic Obstructive Pulmonary Disease (COPD)

Femme et Homme

  • | Pays :
    • -
  • | Organes :
    • -
  • | Spécialités :
    • -

Extrait

The primary objective is to evaluate the efficacy of AZD1981 as compared with placebo in patients with moderate to severe COPD.

Critère d'inclusion

  • Chronic Obstructive Pulmonary Disease

Liens